Review: Impact, challenges, and future projections of vaccine trials in Africa

American Journal of Tropical Medicine and Hygiene

Volumn 88, Issue 3, 2013, Pages 414-419

  Idoko, Olubukola T ^a   Kochhar, Sonali ^b   Agbenyega, Tsiri E ^c   Ogutu, Bernhards ^d   Ota, Martin O C ^a  

^a Vaccinology Theme   (Gambia)

^b PATH   (India)

^c KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^d KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS B VACCINE; PNEUMOCOCCUS VACCINE; VACCINE;

AFRICA; AWARENESS; CLINICAL TRIAL (TOPIC); CULTURAL FACTOR; DRUG EFFICACY; EMPLOYMENT; GOOD LABORATORY PRACTICE; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HUMAN; IMMUNIZATION; MORBIDITY; MORTALITY; PREVALENCE; PUBLIC HEALTH; REVIEW; ECONOMICS; IMMUNOLOGY; INFECTION CONTROL; METHODOLOGY; RESEARCH; STANDARD;

AFRICA; CLINICAL TRIALS AS TOPIC; COMMUNICABLE DISEASE CONTROL; HUMANS; RESEARCH; RESEARCH DESIGN; VACCINES;

MLCS; MLOWN;

EID: 84877096959     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.12-0576     Document Type: Review

References (25)

1. Duclos P, Okwo-Bele JM, Gacic-Dabo M, Cherian T, 2009. Global immunization: status, progress, challenges and future. BMC Int Health Hum Rights 9 (Suppl 1): S2.
2. Birn AE, 2011. Small(pox) success? Cien Saude Colet 16: 591-597.
3. Craddock S, 2012. Drug partnerships and global practices. Health Place 18: 481-489.
4. Rehnquist J, 2001. The Globalization of Clinical Trials, a Growing Challenge in Protecting Human Subjects. Available at: http://oig.hhs.gov/oei. Accessed June 25, 2012.
5. Beurret M, Hamidi A, Kreeftenberg H, 2012. Development and technology transfer of Haemophilus influenzae type b conjugate vaccines for developing countries. Vaccine 30: 4897-4906.
6. Louisa M, Takeuchi M, Steiabudy R, Nafrialdi, Takeuchi M, 2012. Current status of phase I clinical trials in Asia: an academic perspectives. Acta Med Indones 44: 71-77.
7. Cutts FT, Zaman SMA, Enwere G, Jaffar S, Levine OS, Okoko BJ, Oluwalana C, Vaughan A, Obaro SK, Leach A, McAdam KP, Biney E, Saaka M, Onwuchekwa U, Yallop F, Pierce NF, Greenwood BM, Adegbola RA, 2005. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365: 1139-1146. (Pubitemid 40417563)
8. Kremer M, 2001. Creating markets for new vaccines, Part I: Rationale. Jaffe AB, Lerner J, Stern S, eds. Innovation Policy and the Economy. Volume 1. Cambridge, MA: MIT Press, 35-72.
9. Shapiro HT, Meslin EM, 2001. Ethical issues in the design and conduct of clinical trials in developing countries. N Engl J Med 345: 138-141.
10. 1998. Ethical issues facing medical research in developing countries. Gambia Government/Medical Research Council Joint Ethical Committee. Lancet 351: 286-287.
11. UNICEF/WHO, 2011. Immunization Summary. Available at: http://www.unesco.org/new/fileadmin/MULTIMEDIA/HQ/ED/GMR. Accessed August 3, 2012.
12. Arenas-Lopez S, Fajardo C, Valls SA, Gracias-Corzo JR, Lima-Rogel MV, Calle G, Leite R, Lobos E, Hume-Wright Q, MacLeod S, 2011. Pediatric clinical trials in Latin America and Guyana: present views of local practitioners and ways to embrace the future. Paediatr Drugs 13: 257-265.
13. Steketee RW, Campbell CC, 2010. Impact of national malaria control scale-up programmes in Africa: magnitude and attribution of effects. Malar J 9: 299.
14. Preziosi MP, Yam A, Ndiaye M, Simagu A, Simondon F, 1997. Practical experiences in obtaining informed consent for a vaccine trial in rural Africa. N Engl J Med 336: 370-373. (Pubitemid 27057191)
15. Cressey D, 2012. Informed consent on trial. Nature 482: 16.
16. Lang T, 2011. Adaptive trial design: could we use this approach to improve clinical trials in the field of global health? Am J Trop Med Hyg 85: 967-970.
17. Fairhead J, Leach M, Small M, 2006. Public engagement with science? Local understandings of a vaccine trial in the Gambia. J Biosoc Sci 38: 103-116. (Pubitemid 44367124)
18. UNESCO, 2010. Education for All Global Monitoring Report. Reaching the Marginalized. Available at: http://www.unesco.org/new/fileadmin/MULTIMEDIA/HQ/ ED/GMR. Accessed October 17, 2012.
19. Erulkar AS, Muthengi E, 2009. Evaluation of Berhane Hewan: a program to delay child marriage in rural Ethiopia. Int Perspect Sex Reprod Health 35: 6-14.
20. Ota MO, Idoko OT, Ogundare EO, Afolabi MO, 2012. Human immune responses to vaccines in the first year of life: biological, socio-economic and ethical issues: a viewpoint. Vaccine 2012 Jun 19 [Epub ahead of print].
21. Nunez-Wallace KR, Gill CE, Harrison CH, Taylor HM, Charles PD, 2010. Discordance in informed consent response on the basis of demographic factors: brief report. Intellect Dev Disabil 48: 175-179.
22. Sow SO, Okoko BJ, Diallo A, Viviani S, Carlone G, Tapia M, Borrow R, Akinsola AK, Arduin P, Findlow H, Elie C, Haidara FC, Parulekar V, Chaumont J, Martellet L, Diallo F, Idoko OT, Tang Y, Plikaytis BD, Kulkarni PS, Marchetti E, Laforce FM, Preziosi MP, 2011. Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. N Engl J Med 364: 2293-2304.
23. Howie SR, 2011. Blood sample volumes in child health research: review of safe limits. Bull World Health Organ 89: 46-53.
24. Kaufmann JR, Feldbaum H, 2009. Diplomacy and the polio immunization boycott in northern Nigeria. Health Aff (Millwood) 28: 1091-1101.
25. Englev E, Petersen KP, 2003. ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives [in Danish]. Ugeskr Laeger 165: 1659-1662. (Pubitemid 38094650)